Choroidal Thickness in Glaucoma Patients and Healthy Controls

University of Zurich200 enrolled

Overview

With the new software tool (EDI, enhanced depth imaging) of the Spectralis® spectral-domain optical coherence tomography (SD-OCT) it is possible to visualize and measure the choroidal thickness. In glaucoma a vascular component is known. Therefore a difference of choroidal thickness in glaucoma patients and healthy controls is proposed. * Trial with medical device

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Glaucoma Patients and Healthy Controls

Interventions

Spectralis® SD-OCT, Heidelberg Engineering GmbH, HDEVICE

Measurement of the choroidal thickness with Spectralis® SD-OCT

Eligibility

Sex: ALLMin age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion criteria: for both groups (glaucoma study group and control group): men and women of at least 50 years of age for the glaucoma study group: diagnosis of primary open angle glaucoma (POAG) Exclusion criteria: for both groups (glaucoma study group and control group): * less then 50 years of age * any pathology of the central retina * any optic nerve disorder other then glaucoma * retinal vascular disorder for the glaucoma study group: other glaucoma diagnosis then primary open angle glaucoma for the control group: any diagnosis of glaucoma

Locations (1)

University Hospital Zurich, Ophthalmic Clinic

Zurich, Canton of Zurich, Switzerland

Outcomes

Primary Outcomes

COV

Time frame: t0

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.